In the present study, TriL treatment showed a dose-dependent inhibitory effect on carotid artery ligation-induced intimal hyperplasia and reduced PCNA expression in the neointima, which implies TriL may have therapeutic potential for cerebrovascular diseases. The gene discussed is TRIL; the disease is cerebrovascular disorder.